Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case reportYong Zhang, Guiyun Cui, Zhouao Zhang et al.|Journal of Neurology|2024Cited by 28